Inflammatory bowel disease (IBD) is a complex disorder characterized by chronic
inflammation of the gastrointestinal tract (GIT). IBD mainly includes two distinct diseases …

It is already well-known that visceral adipose tissue is inseparably related to the
pathogenesis, activity, and general outcome of inflammatory bowel disease (IBD). We are …

Ulcerative colitis (UC) has become a global epidemic, and the lack of an effective cure
highlights the necessity and urgency to explore novel therapies. Sijunzi Decoction (SJZD), a …

Inflammatory bowel disease (IBD), including both ulcerative colitis and Crohn's disease, is a
chronic inflammatory disease of the gastrointestinal tract that is thought to arise from a …

Diet, lifestyle, and gut microbiota composition are key risk factors for the progression of colon
cancer. Probiotics are living microorganisms that can offer health benefits to the parasitifer …

Abstract Background and Aims To advance the understanding of inflammatory bowel
disease [IBD] pathophysiology, we compared the mucosal and plasma metabolomes …

Inflammatory bowel disease (IBD) is a chronic non-specific inflammatory disease that occurs
in the intestinal tract. It is mainly divided into two subtypes, ie, the Crohn's disease (CD) and …

Patients with inflammatory bowel disease (IBD) are at substantially high risk for colorectal
cancer (CRC). IBD-associated CRC accounts for roughly 10% to 15% of the annual mortality …

Abstract Background and Aims Proton pump inhibitors (PPI) affect the gastrointestinal
microbiota, which is thought to play a role in the pathogenesis of ulcerative colitis (UC) …

The protective intestinal epithelial barrier is constantly exposed to more than 100 trillion
commensal microorganisms (bacteria, archaea, viruses, and fungi), ie, the microbiome …